CompletedNCT04596865
Recurrence After Whipple's (RAW) Study
Studying Carcinoma of the ampulla of Vater
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital Plymouth NHS Trust
- Principal Investigator
- Somaiah ArooriUniversity Hospitals Plymouth NHS Trust
- Intervention
- Pancreaticoduodenectomy(procedure)
- Enrollment
- 1484 enrolled
- Eligibility
- All sexes
- Timeline
- 2020 – 2023
Study locations (29)
- Monash Medical Centre, Clayton, Victoria, Australia
- Medical University Innsbruck, Anichstr. 35 A, Innsbruck, Austria
- Azienda Ospedaliero - Universitaria Di Sassari, Sassari, Sardinia, Italy
- Azienda Ospedaliero - Universitaria Policlinico Umberto I, Rome, Italy
- Salvador Zubirán National Institute of Health Sciences and Nutrition, Tlalpan, Mexico City, Mexico
- Shaukat Khanum Memorial Cancer Hospital, Lahore, Pakistan
- Hospital Clinic de Barcelona, Barcelona, Spain
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
- Hospital Universitario Miguel Servet, Zaragoza, Spain
- Ibn Sena Specialized Hospital, Khartoum, Sudan
- Derriford Hospital, Plymouth, Devon, United Kingdom
- Royal Blackburn Teaching Hospital, Blackburn, Lancashire, United Kingdom
- Royal Surrey County Hospital, Guildford, Surrey, United Kingdom
- Singleton Hospital, Swansea, Wales, United Kingdom
- University Hospital Coventry, Coventry, Warwickshire, United Kingdom
- +14 more locations on ClinicalTrials.gov
Collaborators
University of Plymouth
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04596865 on ClinicalTrials.govOther trials for Carcinoma of the ampulla of Vater
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07282912Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) LevelsYale University
- RECRUITINGPHASE3NCT07081360Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary CancerMinia University
- RECRUITINGNANCT06801899ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary CancerInsel Gruppe AG, University Hospital Bern
- RECRUITINGNANCT05780684Individualized Dose Escalation of 5-FU for Gastrointestinal CancerDartmouth-Hitchcock Medical Center
- ENROLLING BY INVITATIONNANCT06076252Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary CarcinomaAffiliated Hospital of Guangdong Medical University
- RECRUITINGNANCT06068023The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.Fondazione Poliambulanza Istituto Ospedaliero
- RECRUITINGNANCT05497531Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic CancersUniversity of California, Irvine
- RECRUITINGPHASE1, PHASE2NCT05116072Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative FistulaUniversity Hospital, Lille